Determining Relationships Among Maternity Stress & Sleep
NCT ID: NCT02133963
Last Updated: 2015-05-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
17 participants
OBSERVATIONAL
2014-05-31
2015-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Post-natal Depression and Chronic Stress
NCT03088319
Neurophysiology of Postpartum Depression in an Experimental Model of Pregnancy and Parturition
NCT01762943
Interaction Between Genetic Factors and Maternal Stressors During Pregnancy in the Risk of Postpartum Depression
NCT01648816
Sleep, Oxytocin and Reward Processing in Women in the Postpartum Phase
NCT06711809
A Prospective Study of Postpartum Depression in Women With Major Depression
NCT01328613
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
women with no history of depression
Non-Probability Sample of women with no history of depression
No interventions assigned to this group
women with a past depression history
Non-Probability Sample of women with a past history of depression
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* women between 18-45 years of age
* women with a past history of depression
* women with no past history of depression
Exclusion Criteria
* over 45 years of age
* pregnancy gestation \> 22 weeks at study enrollment
* multiparity
* non-singleton pregnancy
* prior termination of pregnancy at \>12 weeks gestation
* prior loss of pregnancy \>2 times at \<12 weeks gestation
* prior history of stillbirth
* current substance use (alcohol and/or elicit drugs)
* current chronic steroid use
* current use of antidepressants, anti-anxiety medications, mood-stabilizers, psychotropic medications, progesterone treatment, or sleep medications
* current tobacco use
* diagnosed obstructive sleep apnea,
* diagnosed restless legs syndrome (RLS)
* certain cancers
* pre-gestational diabetes
* a body mass index (BMI) of \> 40kg/m2 just prior to pregnancy
* chronic hypertension (documented or taking medication for hypertension)
* gestational hypertension
* preeclampsia
* current anemia
* current or past history of psychosis, schizoaffective disorder,or bipolar disorder
* current depression
18 Years
45 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
North Carolina Translational and Clinical Sciences Institute
OTHER
University of North Carolina, Chapel Hill
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Shannon Crowley, PhD
Postdoctoral Fellow
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Shannon K Crowley, PhD
Role: PRINCIPAL_INVESTIGATOR
University of North Carolina, Chapel Hill
Susan S Girdler, PhD
Role: STUDY_CHAIR
University of North Carolina, Chapel Hill
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
UNC Chapel Hill
Chapel Hill, North Carolina, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
13-3229
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.